Dr. Williams, GlaxoSmithKline receive AFUD's presidential award
Chicago-The American Foundation for Urologic Disease honored RichardD. Williams, MD, with its 2003 presidential award on Monday. Dr. Williams(shown), professor and chairman of the department of urology at the Universityof Iowa, Iowa City, was recognized for his commitment to urology, includinghis service as chair of the grant review committee for the AUA/AFUD researchscholar program for the past 5 years. Also receiving a presidential awardwas pharmaceutical manufacturer GlaxoSmithKline, which was recognized forits commitment to patient education. Both awards were presented at AFUD'sannual benefit and gala here.Separately, AFUD named Chung Lee, PhD, of Northwestern University, asoutstanding preceptor, and John McConnell, MD, of the University of TexasSouthwestern, as outstanding scholar.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.